Table of Contents
Chapter 1. Global Autoimmune Disease Diagnostics Market Executive Summary
1.1. Global Autoimmune Disease Diagnostics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Test Type
1.3.3. By Disease
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Autoimmune Disease Diagnostics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Autoimmune Disease Diagnostics Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Autoimmune Diseases
3.1.2. Advancements in Diagnostic Technologies
3.1.3. Increased Awareness and Healthcare Expenditure
3.2. Market Challenges
3.2.1. High Costs and Limited Accessibility
3.3. Market Opportunities
3.3.1. Emerging Markets
3.3.2. Personalized Medicine
Chapter 4. Global Autoimmune Disease Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Autoimmune Disease Diagnostics Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Autoimmune Disease Diagnostics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Consumables & Assay Kits
5.2.2. Instruments
Chapter 6. Global Autoimmune Disease Diagnostics Market Size & Forecasts by Test Type 2022-2032
6.1. Segment Dashboard
6.2. Global Autoimmune Disease Diagnostics Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Routine Laboratory Tests
6.2.2. Inflammatory Markers
6.2.3. Autoantibodies & Immunologic Test
6.2.4. Other Tests
Chapter 7. Global Autoimmune Disease Diagnostics Market Size & Forecasts by Disease 2022-2032
7.1. Segment Dashboard
7.2. Global Autoimmune Disease Diagnostics Market: Disease Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Rheumatoid Arthritis
7.2.2. Systemic Lupus Erythematosus
7.2.3. Sjogren's Syndrome
7.2.4. Thyroiditis
7.2.5. Scleroderma
7.2.6. Other Diseases
Chapter 8. Global Autoimmune Disease Diagnostics Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Autoimmune Disease Diagnostics Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Clinical Laboratories
8.2.2. Hospitals
8.2.3. Other End Users
Chapter 9. Global Autoimmune Disease Diagnostics Market Size & Forecasts by Region 2022-2032
9.1. North America Autoimmune Disease Diagnostics Market
9.1.1. U.S. Autoimmune Disease Diagnostics Market
9.1.1.1. Product breakdown size & forecasts, 2022-2032
9.1.1.2. Test Type breakdown size & forecasts, 2022-2032
9.1.1.3. Disease breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Autoimmune Disease Diagnostics Market
9.2. Europe Autoimmune Disease Diagnostics Market
9.2.1. U.K. Autoimmune Disease Diagnostics Market
9.2.2. Germany Autoimmune Disease Diagnostics Market
9.2.3. France Autoimmune Disease Diagnostics Market
9.2.4. Spain Autoimmune Disease Diagnostics Market
9.2.5. Italy Autoimmune Disease Diagnostics Market
9.2.6. Rest of Europe Autoimmune Disease Diagnostics Market
9.3. Asia-Pacific Autoimmune Disease Diagnostics Market
9.3.1. China Autoimmune Disease Diagnostics Market
9.3.2. India Autoimmune Disease Diagnostics Market
9.3.3. Japan Autoimmune Disease Diagnostics Market
9.3.4. Australia Autoimmune Disease Diagnostics Market
9.3.5. South Korea Autoimmune Disease Diagnostics Market
9.3.6. Rest of Asia Pacific Autoimmune Disease Diagnostics Market
9.4. Latin America Autoimmune Disease Diagnostics Market
9.4.1. Brazil Autoimmune Disease Diagnostics Market
9.4.2. Mexico Autoimmune Disease Diagnostics Market
9.4.3. Rest of Latin America Autoimmune Disease Diagnostics Market
9.5. Middle East & Africa Autoimmune Disease Diagnostics Market
9.5.1. Saudi Arabia Autoimmune Disease Diagnostics Market
9.5.2. South Africa Autoimmune Disease Diagnostics Market
9.5.3. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Siemens
10.3.3. Abbott
10.3.4. Danaher
10.3.5. Bio-Rad Laboratories
10.3.6. Grifols
10.3.7. Trinity Biotech
10.3.8. Werfen
10.3.9. HYCOR Biomedical
10.3.10. EUROIMMUN AG
10.3.11. Oncimmune
10.3.12. HTG Molecular Diagnostics
10.3.13. Seramun Diagnostica GmbH
10.3.14. Exagen Inc.
10.3.15. Cambridge Life Sciences Limited
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes